Dergiler / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 1

Tracheostomy in COVID-19 Patients: A Retrospective Observational Study

Sayfa
77–81
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In the early tracheostomy group, ICU LOS and the MV duration were significantly shorter.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: During the COVID-19 pandemic, many patients require intensive care unit (ICU) hospitalization with mechanical ventilation (MV).
📊
Temel Bulgular & Veri:There is still no clear information about the timing and indications of tracheostomy in COVID-19 cases.
💡
Sonuç & Katkı:In the early tracheostomy group, ICU LOS and the MV duration were significantly shorter.
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: During the COVID-19 pandemic, many patients require intensive care unit (ICU) hospitalization with mechanical ventilation (MV). There is still no clear information about the timing and indications of tracheostomy in COVID-19 cases. We aimed to evaluate the relationship between the timing of tracheostomy and outcomes of critical COVID-19 cases. Materials and Methods: This single-center, retrospective, observational study included patients with COVID-19 who were intubated in the ICU between November 1, 2020 and February 1, 2021, and underwent percutaneous tracheostomy. Demographic data of all patients, the day each patient underwent a percutaneous tracheostomy, the complications related to the procedure, laboratory data, mortality, MV duration, and ICU length of stay (LOS) were recorded. Results: The study included 33 critically ill patients with COVID-19 undergoing tracheostomy. Among these cases, 18 (54.5%) patients who underwent tracheostomy within 14 days after intubation comprised the early group; 15 (45.5%) patients who underwent tracheostomy after 14 days comprised the late tracheostomy group. There was no difference between the two groups in mortality. The median ICU LOS was 33.0 (25.0–37.0) days, and it was longer in late group [35.0 (30.0–37.0) vs. 29.5 (18.8–34.5), p=0.046]. The median duration of MV was 27.0 (18.0–33.5) days, which was longer in late group [29 (25.0–37.0) vs. 19 (12.8–29.0), p=0.004]. Conclusion: In critical COVID-19 cases, there was no difference between groups in terms of mortality. In the early tracheostomy group, ICU LOS and the MV duration were significantly shorter.

🔖

Bu Makaleye Atıf Yap

DAL, H. C., TURAN, S. (2022). Tracheostomy in COVID-19 Patients: A Retrospective Observational Study. Erciyes Medical Journal, Cilt: 44 - Sayı: 1, 77–81. https://ajindex.com/articles/502164

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses 2020; 12(2): 135
  2. Immovilli P, Morelli N, Antonucci E, Radaelli G, Barbera M, Guidetti D. COVID-19 mortality and ICU admission: the Italian experience. Crit Care 2020; 24(1): 228
  3. Bösel J, Schiller P, Hook Y, Andes M, Neumann JO, Poli S, et al. Stroke-related early tracheostomy versus prolonged orotracheal intubation in neurocritical care trial (SETPOINT): a randomized pilot trial. Stroke 2013; 44(1): 21–8
  4. Robba C, Galimberti S, Graziano F, Wiegers EJA, Lingsma HF, Iaquaniello C, et al; CENTER-TBI ICU Participants and investigators. Tracheostomy practice and timing in traumatic brain-injured patients: a CENTER-TBI study. Intensive Care Med 2020; 46(5): 983–94
  5. American Academy of Otolaryngology and Head and Neck Surgery. AAO Position statement: Tracheotomy recommendations during the COVID-19 pandemic. Available from: URL: https://www.entnet.org/ resource/tracheotomy-recommendations-during-the-covid-19-pandemic-2/. Accessed Apr 22, 2021
  6. Schultz MJ, Pattnaik R, Dondorp AM. Walking the line between benefit and harm from tracheostomy in COVID-19. Lancet Respir Med 2020; 8(7): 656–7
  7. World Health Organization. Clinical management of severe acute respiratory infection when novel Coronavirus (2019-nCoV) infection is suspected: Interim guidance. Available from: URL: https://apps.who. int/iris/handle/10665/330893 Accessed Nov 12, 2020
  8. Tang Y, Wu Y, Zhu F, Yang X, Huang C, Hou G, et al. Tracheostomy in 80 COVID-19 patients: A Multicenter, retrospective, observational study. Front Med (Lausanne) 2020; 7: 615845
  9. Queen Elizabeth Hospital Birmingham COVID-19 airway team. Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort study. Br J Anaesth 2020; 125(6): 872–9
  10. Rumbak MJ, Newton M, Truncale T, Schwartz SW, Adams JW, Hazard PB. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Care Med 2004; 32(8): 1689–94
  11. Griffiths J, Barber VS, Morgan L, Young JD. Systematic review and meta-analysis of studies of the timing of tracheostomy in adult patients undergoing artificial ventilation. BMJ 2005; 330(7502): 1243
  12. Young D, Harrison DA, Cuthbertson BH, Rowan K; TracMan Collaborators. Effect of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: the TracMa